Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System.

MLA

Makarem, Maisam, et al. “Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System.” Current Oncology, vol. 28, no. 5, Oct. 2021, pp. 3268–79. EBSCOhost, https://doi.org/10.3390/curroncol28050284.

APA

Makarem, M., Ezeife, D. A., Smith, A. C., Li, J. J. N., Law, J. H., Tsao, M.-S., & Leighl, N. B. (2021). Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System. Current Oncology, 28(5), 3268–3279. https://doi.org/10.3390/curroncol28050284

Chicago

Makarem, Maisam, Doreen A. Ezeife, Adam C. Smith, Janice J. N. Li, Jennifer H. Law, Ming-Sound Tsao, and Natasha B. Leighl. 2021. “Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System.” Current Oncology 28 (5): 3268–79. doi:10.3390/curroncol28050284.